These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 17123082

  • 1. Pure red cell aplasia in a patient of chronic granulocyte leukemia associated with imatinib.
    Meng HT, Li Y, Jin J, Qian WB, Yang CM.
    Ann Hematol; 2007 Mar; 86(3):231-2. PubMed ID: 17123082
    [No Abstract] [Full Text] [Related]

  • 2. Development of multiple myeloma in a patient with chronic myeloid leukemia after treatment with imatinib mesylate.
    Garipidou V, Vakalopoulou S, Tziomalos K.
    Oncologist; 2005 Mar; 10(6):457-8. PubMed ID: 15967839
    [No Abstract] [Full Text] [Related]

  • 3. Imatinib-related bone marrow aplasia after complete cytogenetic response in chronic myeloid leukemia.
    Khan KA, Junaid A, Siddiqui NS, Mukhtar K, Siddiqui S.
    J Coll Physicians Surg Pak; 2008 Mar; 18(3):176-8. PubMed ID: 18460249
    [Abstract] [Full Text] [Related]

  • 4. Imatinib-associated hyperpigmentation, a side effect that should be recognized.
    Mcpherson T, Sherman V, Turner R.
    J Eur Acad Dermatol Venereol; 2009 Jan; 23(1):82-3. PubMed ID: 18384557
    [No Abstract] [Full Text] [Related]

  • 5. [Psoriasis vulgaris exacerbated by imatinib therapy in chronic myelogenous leukemia].
    Shimizu K, Kuroda H, Kida M, Watanabe H, Shirao S, Akiyama T, Fujimi A, Tanaka I, Sato T, Matsunaga T, Niitsu Y.
    Rinsho Ketsueki; 2005 Oct; 46(10):1152-5. PubMed ID: 16440780
    [Abstract] [Full Text] [Related]

  • 6. Are there new clinical parameters useful to predict response in chronic myeloid leukemia in the imatinib era?
    Breccia M, Alimena G.
    Leuk Res; 2009 Nov; 33(11):1450-1. PubMed ID: 19615745
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Male patients with chronic myeloid leukemia treated with imatinib involved in healthy pregnancies: report of five cases.
    Breccia M, Cannella L, Montefusco E, Frustaci A, Pacilli M, Alimena G.
    Leuk Res; 2008 Mar; 32(3):519-20. PubMed ID: 17804066
    [No Abstract] [Full Text] [Related]

  • 10. Imatinib mesylate (Glivec, Gleevec) in the treatment of chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors (GIST).
    Hochhaus A.
    Ann Hematol; 2004 Mar; 83 Suppl 1():S65-6. PubMed ID: 15124676
    [No Abstract] [Full Text] [Related]

  • 11. STI-571 (Gleevec) in the treatment of chronic myeloid leukaemia.
    Kumar L, Kumari M, Menon H.
    Natl Med J India; 2002 Mar; 15(5):298. PubMed ID: 12502149
    [No Abstract] [Full Text] [Related]

  • 12. Long-term molecular efficacy and safety of imatinib in a patient with chronic myeloid leukaemia after renal transplantation.
    Thierry A, Dreyfus B, Bridoux F, Abou Ayache R, Milin S, Guilhot F, Touchard G.
    Nephrol Dial Transplant; 2007 Jun; 22(6):1791-2. PubMed ID: 17308316
    [No Abstract] [Full Text] [Related]

  • 13. In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate'.
    Rosti G, Martinelli G, Baccarani M.
    Nat Med; 2007 Jan; 13(1):15; author reply 15-6. PubMed ID: 17206121
    [No Abstract] [Full Text] [Related]

  • 14. In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate'.
    Atallah E, Kantarjian H, Cortes J.
    Nat Med; 2007 Jan; 13(1):14; author reply 15-6. PubMed ID: 17206119
    [No Abstract] [Full Text] [Related]

  • 15. In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate'.
    Gambacorti-Passerini C, Tornaghi L, Franceschino A, Piazza R, Corneo G, Pogliani E.
    Nat Med; 2007 Jan; 13(1):13-4; author reply 15-6. PubMed ID: 17206117
    [No Abstract] [Full Text] [Related]

  • 16. In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate'.
    Hatfield A, Owen S, Pilot PR.
    Nat Med; 2007 Jan; 13(1):13; author reply 15-6. PubMed ID: 17206118
    [No Abstract] [Full Text] [Related]

  • 17. Vitiligo-like lesions in an adult patient treated with Imatinib mesylate.
    Cerchione C, Fabbricini R, Pane F, Luciano L.
    Leuk Res; 2009 Aug; 33(8):e104-5. PubMed ID: 19232719
    [No Abstract] [Full Text] [Related]

  • 18. Imatinib-lnduced agranulocytosis in a patient with chronic myelogenous leukemia in remission.
    Khouri S, Kotliroff A, Lishner M, Amital H.
    Isr Med Assoc J; 2008 Apr; 10(4):320-1. PubMed ID: 18548994
    [No Abstract] [Full Text] [Related]

  • 19. Ocular side effects in chronic myeloid leukemia patients treated with imatinib.
    Breccia M, Gentilini F, Cannella L, Latagliata R, Carmosino I, Frustaci A, Alimena G.
    Leuk Res; 2008 Jul; 32(7):1022-5. PubMed ID: 18061664
    [Abstract] [Full Text] [Related]

  • 20. FDA approves Gleevec for pediatric leukemia.
    FDA Consum; 2003 Jul; 37(4):6. PubMed ID: 12971334
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.